4//SEC Filing
Nabiey Romin 4
Accession 0001809519-25-000124
CIK 0001809519other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:06 PM ET
Size
13.3 KB
Accession
0001809519-25-000124
Insider Transaction Report
Form 4
Nabiey Romin
Chief Accounting Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2025-09-08+10,201→ 147,493 total - Tax Payment
Class A Common Stock
2025-09-08$4.00/sh−799$3,196→ 145,276 total - Tax Payment
Class A Common Stock
2025-09-08$4.00/sh−3,650$14,600→ 143,843 total - Exercise/Conversion
Restricted Stock Unit
2025-09-08−10,201→ 40,803 total→ Class A Common Stock (10,201 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-09-08−2,232→ 22,323 total→ Class A Common Stock (2,232 underlying) - Exercise/Conversion
Class A Common Stock
2025-09-08+2,232→ 146,075 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
- [F3]The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001924892
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 5:06 PM ET
- Size
- 13.3 KB